Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Non-cash Items (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Non-cash Items readings, the most recent being $5.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 11.83% year-over-year to $5.9 million, compared with a TTM value of $5.9 million through Dec 2025, down 11.83%, and an annual FY2025 reading of $5.9 million, down 11.83% over the prior year.
  • Non-cash Items hit $5.9 million in Q4 2025 for Apellis Pharmaceuticals, down from $6.7 million in the prior quarter.
  • The five-year high for Non-cash Items was $317.0 million in Q4 2022, with the low at $5.9 million in Q4 2025.
  • Median Non-cash Items over the past 5 years was $253.9 million (2023), compared with a mean of $175.1 million.
  • The sharpest move saw Non-cash Items soared 4714.01% in 2021, then crashed 97.36% in 2024.
  • Year by year, Non-cash Items stood at $291.8 million in 2021, then grew by 8.64% to $317.0 million in 2022, then dropped by 19.9% to $253.9 million in 2023, then tumbled by 97.36% to $6.7 million in 2024, then fell by 11.83% to $5.9 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $5.9 million, $6.7 million, and $253.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.